[1]
Caetano, R. et al. 2020. The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health. Revista de Saúde Pública. 54, (Feb. 2020), 22. DOI:https://doi.org/10.11606/s1518-8787.2020054001693.